OPTI — OptiBiotix Health Cashflow Statement
0.000.00%
Last trade - 00:00- £18.12m
- £16.86m
- £0.64m
Annual cashflow statement for OptiBiotix Health, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 13 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.17 | -1.11 | -1.37 | -2.49 | -1.7 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.137 | 0.137 | 0.06 | 0.011 | 0.011 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.088 | -0.201 | -0.548 | 1.15 | -0.048 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.72 | -0.928 | -1.56 | -1.11 | -1.53 |
| Capital Expenditures | -0.595 | -0.35 | -0.194 | -0.168 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | -0.163 | 1.11 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | -0.595 | -0.35 | -0.194 | -0.331 | 1.11 |
| Financing Cash Flow Items | 0.617 | 0.747 | 2.9 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.45 | 1.69 | 2.9 | 0.485 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.869 | 0.409 | 1.14 | -0.955 | -0.417 |